print
Purdue Pharma Reaches Tentative Deal To Settle Thousands Of Opioid Lawsuits
by applewood

    Details of the deal ⁠— like how the money will be divvied up — are still being worked out. The settlement, if enacted, would mean Purdue will file for bankruptcy and divest from pharmaceutical holdings worldwide.

    "Which means the people who were front and center in causing this epidemic, in my view, won't be able to go out and repeat their playbook in Asia, South America or Africa," Ohio Attorney General Dave Yost, who is part of the pending deal, told NPR.

    Under the terms of the proposal, future revenue from the sale of Oxycontin would go into a trust designed to help communities struggling with the opioid epidemic.

    The tentative deal would relaunch the Purdue company under non-Sackler ownership. The newly formed company will be managed by a group of trustees.